IL133138A0 - Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor - Google Patents

Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor

Info

Publication number
IL133138A0
IL133138A0 IL13313898A IL13313898A IL133138A0 IL 133138 A0 IL133138 A0 IL 133138A0 IL 13313898 A IL13313898 A IL 13313898A IL 13313898 A IL13313898 A IL 13313898A IL 133138 A0 IL133138 A0 IL 133138A0
Authority
IL
Israel
Prior art keywords
thiazolidinedione
diabetes
alpha
treatment
glucosidase inhibitor
Prior art date
Application number
IL13313898A
Other languages
English (en)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9712865.6A external-priority patent/GB9712865D0/en
Priority claimed from GBGB9806708.5A external-priority patent/GB9806708D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of IL133138A0 publication Critical patent/IL133138A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL13313898A 1997-06-18 1998-06-15 Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor IL133138A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9712865.6A GB9712865D0 (en) 1997-06-18 1997-06-18 Novel method of treatment
GBGB9806708.5A GB9806708D0 (en) 1998-03-27 1998-03-27 Novel method
PCT/EP1998/003691 WO1998057635A1 (en) 1997-06-18 1998-06-15 Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor

Publications (1)

Publication Number Publication Date
IL133138A0 true IL133138A0 (en) 2001-03-19

Family

ID=26311746

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13313898A IL133138A0 (en) 1997-06-18 1998-06-15 Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor

Country Status (24)

Country Link
EP (1) EP0975343A1 (ko)
JP (1) JP2001523271A (ko)
KR (1) KR20010013845A (ko)
CN (1) CN1274282A (ko)
AP (1) AP9901720A0 (ko)
AR (2) AR014881A1 (ko)
AU (1) AU8799998A (ko)
BG (1) BG103966A (ko)
BR (1) BR9810186A (ko)
CA (1) CA2294134A1 (ko)
CO (1) CO4940453A1 (ko)
DZ (1) DZ2519A1 (ko)
EA (1) EA200000040A1 (ko)
IL (1) IL133138A0 (ko)
MA (1) MA26510A1 (ko)
NO (1) NO996270L (ko)
NZ (1) NZ501345A (ko)
OA (1) OA11631A (ko)
PE (1) PE89199A1 (ko)
PL (1) PL337577A1 (ko)
SK (1) SK179499A3 (ko)
TR (1) TR199903072T2 (ko)
UY (1) UY25051A1 (ko)
WO (1) WO1998057635A1 (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0009934A (pt) 1999-04-23 2002-06-04 Smithkline Beecham Plc Produto farmacêutico
CN100384430C (zh) 2001-04-04 2008-04-30 奥索-麦克尼尔药品公司 含有葡萄糖重吸收抑制剂和维生素a类-x受体调节剂的联合治疗
CA2442917C (en) 2001-04-04 2011-02-01 Ortho-Mcneil Pharmaceutical, Inc. Combination therapy comprising glucose reabsorption inhibitors and ppar modulators
FR2832930A1 (fr) * 2001-12-03 2003-06-06 Lipha Composition pharmaceutique comprenant un inhibiteur d'alpha-glucosidase et un derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete
JP2004067575A (ja) * 2002-08-06 2004-03-04 Yaizu Suisankagaku Industry Co Ltd 糖尿病治療薬効果促進剤
CN101121004B (zh) * 2006-08-08 2010-07-21 鲁南制药集团股份有限公司 含有胰岛素增敏剂和米格列醇的药物组合物
CN101584688B (zh) * 2008-05-24 2010-11-10 鲁南制药集团股份有限公司 一种治疗糖尿病及其并发症的药物组合物
CN101584705B (zh) * 2008-05-24 2010-10-27 鲁南制药集团股份有限公司 一种治疗糖尿病及其并发症的药物组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5900435A (en) * 1991-08-26 1999-05-04 Pharmacia & Upjohn Company Composition, food product and uses of 3-guanidinopropionic acid
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes

Also Published As

Publication number Publication date
AR013352A1 (es) 2000-12-27
WO1998057635A1 (en) 1998-12-23
AP9901720A0 (en) 1999-12-31
UY25051A1 (es) 2000-09-29
JP2001523271A (ja) 2001-11-20
KR20010013845A (ko) 2001-02-26
AU8799998A (en) 1999-01-04
MA26510A1 (fr) 2004-12-20
TR199903072T2 (xx) 2000-07-21
OA11631A (en) 2004-11-22
AR014881A1 (es) 2001-04-11
PE89199A1 (es) 1999-10-23
BG103966A (bg) 2000-07-31
CO4940453A1 (es) 2000-07-24
PL337577A1 (en) 2000-08-28
EA200000040A1 (ru) 2000-08-28
SK179499A3 (en) 2000-11-07
NO996270D0 (no) 1999-12-17
DZ2519A1 (fr) 2003-02-01
NO996270L (no) 1999-12-17
NZ501345A (en) 2001-10-26
CN1274282A (zh) 2000-11-22
BR9810186A (pt) 2000-08-08
EP0975343A1 (en) 2000-02-02
CA2294134A1 (en) 1998-12-23

Similar Documents

Publication Publication Date Title
AP9901719A0 (en) Treatment of diabetes with thiazolidinedione and metormin
HU9802721D0 (en) Method and composition for the treatment and prevention of hyperuricemia
PL343123A1 (en) Treatment of diabetes with rosiglitazone and insulin
IL133138A0 (en) Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor
AP9901717A0 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
IL134045A0 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
IL133907A0 (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
AU7688998A (en) Use of metalloproteinase inhibitors in the treatment and prevention of pulmonaryemphysema
AU4107797A (en) Compounds for the treatment and prevention of diabetes
HUP0002668A3 (en) Treatment of diabetes with thiazolidinedione and metformin
HUP9903979A3 (en) Use of nitric oxidesynthase inhibitors to treat or prevent type ii diabetes
HUP0002669A3 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
IL121656A0 (en) Diagnosis prevention and treatment of diabetes
ID24355A (id) Pengobatan diabetes mellitus dengan tiazolidinadion dan inhibitor alfa-glukosidase
GB9815149D0 (en) Treatment of diabetes
GB9700481D0 (en) Assay and method of treatment
GB9609897D0 (en) Treatment of diabetes
GB9714804D0 (en) Treatment of substrates
GB9703008D0 (en) Treatment of substrates
GB9706608D0 (en) Decontamination and treatment of metal surfaces
GB9715198D0 (en) Treatment and prophylaxis of infarction
GB9719596D0 (en) Treatment and prophylaxis of infarction